Literature DB >> 21910749

Management of neutropenic enterocolitis in children with cancer.

Nicklas Sundell1, Håkan Boström, Mats Edenholm, Jonas Abrahamsson.   

Abstract

AIM: To describe the symptoms, clinical management and short-term outcome in a series of paediatric oncology patients with severe typhlitis following conservative treatment.
METHODS: Twelve episodes of severe typhlitis in 11 children with cancer treated at the paediatric oncology ward at Queen Silvias Children's Hospital between 1995 and 2006 were analysed retrospectively. Data on symptoms, radiological findings, laboratory status and treatment as well as outcome were collected and analysed.
RESULTS: In all episodes, the classical signs of neutropenia, fever, abdominal pain and thickening of the bowel wall were present. All were successfully treated with bowel rest, broadspectrum antibiotics and supportive care. After recovery from typhlitis, three patients needed surgical intervention because of complications.
CONCLUSION: A high clinical suspicion combined with radiological imaging aids early diagnosis. Predisposing factors for developing typhlitis were haematologic malignancy and treatment with chemotherapy within 3 weeks of onset. Supportive care, bowel rest including parenteral nutrition, correction of cytopenias and aggressive antimicrobial treatment is essential. Measurements of C-reactive protein in blood may be of benefit when assessing the clinical course.
© 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910749     DOI: 10.1111/j.1651-2227.2011.02465.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  6 in total

Review 1.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Current approaches to the management of pneumatosis intestinalis: an American Pediatric Surgical Association membership survey.

Authors:  Shannon N Acker; Sarah Ogle; Emily Cooper; Maxene Meier; Pamela N Peterson; Ann M Kulungowski
Journal:  Pediatr Surg Int       Date:  2022-10-15       Impact factor: 2.003

3.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

4.  Concomitant typhlitis and Clostridium difficile colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient.

Authors:  Parichart Junpaparp; Saranya Buppajarntham; Fernando Vargas Madueno; Gabor Varadi
Journal:  BMJ Case Rep       Date:  2013-04-17

Review 5.  Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Authors:  David Schnell; Elie Azoulay; Dominique Benoit; Benjamin Clouzeau; Pierre Demaret; Stéphane Ducassou; Pierre Frange; Matthieu Lafaurie; Matthieu Legrand; Anne-Pascale Meert; Djamel Mokart; Jérôme Naudin; Frédéric Pene; Antoine Rabbat; Emmanuel Raffoux; Patricia Ribaud; Jean-Christophe Richard; François Vincent; Jean-Ralph Zahar; Michael Darmon
Journal:  Ann Intensive Care       Date:  2016-09-15       Impact factor: 6.925

6.  Neutropenic Enterocolitis Disclosing an Underlying Cyclic Neutropenia.

Authors:  Fatima Ezzahra Lahlimi; Khawla Khalil; Soumia Lahiaouni; Illias Tazi
Journal:  Case Rep Pediatr       Date:  2020-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.